跳至主要内容
临床试验/NL-OMON53251
NL-OMON53251招募中不适用

Metabolic syndrome and vascular damage in relation to accelerated aging in survivors of hematopoietic stem cell transplantation for hematological malignancy. - MetVasA

Prinses Máxima Centrum voor Kinderoncologie0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 64(—)

入选标准

  • Survivors of hematopoietic stem cell transplantation in childhood (at age <=18
  • yr) for a hematological malignancy between 01-01-2002 and 01-01-2021, who are 4
  • years of age or older at inclusion and in follow-up in the late effects clinic
  • of the Princess Maxima Center

排除标准

  • Treatment for second malignancy
  • No understanding of the Dutch language or illiterate

研究者

发起方
Prinses Máxima Centrum voor Kinderoncologie

相似试验